Orexigen Therapeutics (OREX)
Create an Alert
6.35
-0.03 -0.47%
NASDAQ
Jun 19, 11:32AM
BATS Real time
Currency in USD
Orexigen Therapeutics Shareholders Equity:
75.47M for Dec. 31, 2012Orexigen Therapeutics Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 75.47M |
| Sept. 30, 2012 | 49.36M |
| June 30, 2012 | 76.64M |
| March 31, 2012 | 90.94M |
| Dec. 31, 2011 | 99.71M |
| Sept. 30, 2011 | 15.76M |
| June 30, 2011 | 18.95M |
| March 31, 2011 | 24.86M |
| Dec. 31, 2010 | 33.79M |
| Sept. 30, 2010 | 42.80M |
| June 30, 2010 | 54.34M |
| March 31, 2010 | 64.05M |
| Dec. 31, 2009 | 75.90M |
| Sept. 30, 2009 | 88.85M |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
OREX Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Vivus | 175.56M |
| Arena Pharmaceuticals | 80.42M |
| Synergy Pharmaceuticals | 24.83M |
OREX Shareholders Equity Rankings
| Overall |
66th percentile 5588 of 16782 |
| Sector |
72nd percentile 389 of 1410 in Healthcare |
| Industry |
69th percentile 47 of 152 in Drug Manufacturers - Specialty & Generic |
OREX Shareholders Equity Range, Past 5 Years
| Minimum | 15.76M | Sep 2011 |
| Maximum | 99.71M | Dec 2011 |
| Average | 57.38M |
